Vertex Pharmaceuticals Incorporated

VRTX 
(NASDAQ) 
 
$ 168.16 <%= Resources.Global.txtUp %>
Updated 17/04/2019
Change % 0.71% Stock price increasing
Change 1.19 Stock price increasing
Volume 2,151,000
High $ 170.45
Low $ 163.68
Open $ 169.96
ISIN
Prev close $ 166.97
# of shares 255.66M
Market cap 42,991M USD
Intraday

Market closed
Vertex Pharmaceuticals Incorpo
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  168.16 -8.0% Stock price decreasing -7.9% Stock price decreasing -13.6% Stock price decreasing -4.3% Stock price decreasing 6.3% Stock price increasing
Powered by TradingView

News about Vertex Pharmaceuticals Incorpo

  • English
  • Regulatory news

Company profile

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several pipeline candidates targeting this market. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2019 09:54:07
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB4 - 2019-04-21 10:54:07 - 2019-04-21 09:54:07 - 1000 - Website: OKAY